No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.
Futures pointed to a higher open Monday, but the Dow Jones Industrial Average DJIA closed the week 0.5% lower, snapping a three-week win streak, according to Dow Jones Market Data. The S&P 500 SPX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback